ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 92 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $4,056,000 | +25.1% | 602,713 | +2.1% | 0.01% | +25.0% |
| Q3 2014 | $3,242,000 | -16.4% | 590,573 | +56.2% | 0.00% | 0.0% |
| Q2 2014 | $3,876,000 | -13.0% | 378,125 | +1.9% | 0.00% | -20.0% |
| Q1 2014 | $4,457,000 | +13.6% | 371,139 | +6.9% | 0.01% | 0.0% |
| Q4 2013 | $3,925,000 | +7.6% | 347,057 | +2.5% | 0.01% | 0.0% |
| Q3 2013 | $3,647,000 | – | 338,575 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,528,120 | $38,210,000 | 1.53% |
| Cormorant Asset Management, LP | 850,000 | $2,593,000 | 0.41% |
| Palo Alto Investors LP | 1,656,644 | $5,053,000 | 0.24% |
| Granahan Investment Management | 1,745,604 | $5,324,000 | 0.16% |
| Spark Investment Management LLC | 318,500 | $980,000 | 0.13% |
| Opus Point Partners Management, LLC | 57,747 | $176,000 | 0.10% |
| SHEPHERD KAPLAN KROCHUK, LLC | 76,472 | $233,000 | 0.06% |
| Joel Isaacson & Co., LLC | 70,660 | $216,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $229,000 | 0.05% |
| Cornerstone Capital, Inc. | 59,200 | $181,000 | 0.04% |